Speaker illustration

Associate Professor Mihail Chelu

Baylor College of Medicine, Houston (United States of America)

Member of:

European Society of Cardiology

Mortality in atrial fibrillation

Event: EHRA 2019

Topic: Pathophysiology and Mechanisms

Session: Unanswered but key aspects in atrial fibrillation

Thumbnail

Symptomatic atrial fibrillation in the elderly - Atrioventricular node ablation is an attractive strategy - CONTRA

Event: EHRA 2019

Topic: Treatment

Session: Knowledge gaps in clinical atrial fibrillation

Thumbnail

LGE-MRI atrial fibrosis predicts 5 year outcome of atrial fibrillation ablation

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Catheter ablation (Atrial Fibrillation)

Session: Rapid Fire session 4 - Catheter ablation of atrial fibrillation: Predictors and outcome

Thumbnail

Anticoagulant should be prescribed for Atrial fibrillation in stage IV-V kidney disease.

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Anticoagulation

Session: Anticoagulation for non-valvular atrial fibrillation in 2017

Thumbnail

Assessment of pulse wave pressure changes for detection of arrhythmia and comorbidities using a wrist-worn wearable device

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Clinical and epidemiological aspects (Atrial Fibrillation)

Session: Atrial Fibrillation - Clinical and epidemiological aspects

Thumbnail

This platform is supported by

logo Novo Nordisk